CSNK1A1 and malignant colon neoplasm: Knockdown of CK1δ/ε or Treatment With CK1 Inhibitors Downregulate the Level of β-Catenin Acetylation at K49 and Inhibit the Viability and Proliferation in Colon Cancer Cells